Nurix CFO’s Rule 10b5‑1 Sales Spark Insider‑Trading Clues Amid Partnership Setback
Insider sales by Nurix CFO hint at liquidity management amid partnership setbacks, yet long‑term stake signals ongoing confidence.
3 minutes to read
NURIX THERAPEUTICS INC
Hansen Gwenn Executes Routine 10b‑5‑1 Trade, Buying and Selling 1,452 NURIX Shares at $1.86 and $25.00 — $36,000 Proceeds Highlighting Structured Liquidity Management.
Insider trades by Nurix’s chief scientist reveal routine liquidity, not market signals – a balanced plan that keeps executive and investor interests aligned.
3 minutes to read
Nurix Director Buys 22,583 Shares at $23.67, Betting on Post‑Dip Upside Amid 4‑Hour Window and 238% Social‑Media Buzz
Insider buy by Nurix director Gregory Julia P. signals confidence amid a 135% annual gain and rising pipeline—watch the stock’s future upside.
3 minutes to read